AHG Incorporates DeepSeek AI To Revolutionize Medical Diagnostics And Enhance Patient Care

Akso Health Group Integrates AI Technology to Boost Healthcare Services

On February 18, 2025, Akso Health Group (NASDAQ: AHG) announced an exciting development: the integration of advanced artificial intelligence (AI) technology from DeepSeek. This move is aimed at improving AI-driven medical consultations, optimizing healthcare resource allocation, and delivering more accurate and efficient medical services to patients.

Benefits of DeepSeek Integration

The implementation of DeepSeek marks a significant advancement in AI application within the healthcare sector. With its powerful multimodal models and deep learning frameworks, Akso Health aims to upgrade its AI diagnosis system. Here are the key benefits of this integration:

Enhanced Diagnostic Accuracy: By combining text descriptions from patients, medical images, and lab test results, the upgraded system uses Natural Language Processing (NLP) and deep learning. This results in accurate diagnoses and personalized treatment plans.
Improved Efficiency: DeepSeek’s model training framework helps refine AI algorithms, making responses quicker and more precise.
AI-Powered Medical Assistant: Akso Health plans to create an AI assistant for medical professionals. This tool will assist doctors in accessing patient records, analyzing similar cases, and recommending treatment plans, ultimately aiming to boost diagnostic efficiency.
Human-Centric Interaction: The integration places emphasis on empathetic AI interactions. This approach is designed to enhance patient satisfaction during consultations, reducing anxiety and creating a more supportive experience.

CEO’s Vision for AI in Healthcare

Ms. Yilin (Linda) Wang, the CEO of Akso Health, describes this partnership with DeepSeek as a milestone for AI in healthcare. She highlights the company’s objective to utilize this innovative technology to improve diagnosis accuracy and provide superior healthcare services globally.

Looking forward, Akso Health is committed to further exploring AI applications across research and development, health management, and telemedicine, fostering a smarter and more effective healthcare landscape.

About Akso Health Group

Formerly known as Xiaobai Maimai Inc., Akso Health Group began its journey in e-commerce before shifting focus to healthcare equipment and services. The company specializes in medical device sales in China and the United States, alongside operating certain radiotherapy oncology centers in the U.S.

As of March 2024, Akso Health completed the acquisition of Tianjin Deyihui Internet Hospital Co., Ltd. and Tianjin Deyihui Clinic Co., Ltd., which both provide online medical consultations for initial diagnoses, follow-up appointments, and chronic disease management.

Forward-Looking Statements

This announcement includes forward-looking statements as defined in Section 21E of the Securities Exchange Act of 1934. Terms such as “will,” “expects,” “anticipates,” and others indicate future possibilities rather than historical facts. Factors affecting the company’s performance include regulatory challenges, the evolving healthcare landscape, competition, and more.

For more information about Akso Health, interested parties can visit their website at www.ahgtop.com.